0001193125-26-378637 Sample Contracts

BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENT
Sales Agreement • September 1st, 2026 • BridgeBio Oncology Therapeutics, Inc. • Pharmaceutical preparations • New York

BridgeBio Oncology Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC and Cantor Fitzgerald & Co. (each an “Agent” and together, the “Agents”), as follows:

View SourceView Similar (8)